The reference data on this page reflects Accumulation Distribution output applied to Moleculin Biotech's historical daily closing prices. Forecast values and accuracy statistics are presented for informational purposes.
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume The forecast reference data presented here for Moleculin Biotech reflects Accumulation Distribution model output and is intended as reference material for analytical use.
Accumulation Distribution Analysis Today
Moleculin Biotech has current Accumulation Distribution of 4427.15. The accumulation distribution (A/D) indicator shows the degree to which Moleculin Biotech is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Moleculin Biotech to determine if accumulation or reduction is taking place in the market. This value is adjusted by Moleculin Biotech trading volume to give more weight to distributions with higher volume over lower volume.
On March 20 2026 Moleculin Biotech was traded for 2.06 at the closing time. The top price for the day was 2.13 and the lowest listed price was 2.01 . The trading volume for the day was 78.6 K. The trading history from March 20, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.00% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Understanding Moleculin Biotech's price movement is a prerequisite for any investor considering Moleculin as a position. Moleculin Stock price charts are frequently cluttered with noise that can interfere with accurate interpretation.
The following equities are related to Moleculin Biotech within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Moleculin Biotech against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
For traders and investors in Moleculin Biotech, market strength indicators offer a quantitative framework for evaluating the stock's responsiveness to market conditions. These tools help identify when trading Moleculin Biotech shares is most likely to generate favorable returns.
Analyzing Moleculin Biotech's risk indicators provides a critical input for price forecasting and investment risk management. By quantifying the risk in Moleculin Biotech's investment, investors can make more informed decisions about their exposure and hedging strategies.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Moleculin Biotech
Coverage intensity for Moleculin Biotech matters because narrative visibility can influence sentiment, participation, and volatility around the name. Used properly, this context can help investors judge whether visibility is reinforcing the thesis or attracting more speculative pressure.
Short sentiment tied to Moleculin Biotech matters because heavier bearish pressure can change how quickly future price expectations become unstable. The stronger read compares short sentiment with trend behavior, volume, and the broader market narrative.
Common Stock Shares Outstanding
11.8 M
Cash And Short Term Investments
8.9 M
More Resources for Moleculin Stock Analysis
A full view of Moleculin Biotech is built from its financial statements and trend data. Financial ratios summarize performance across earnings and efficiency. The data reflects Moleculin Biotech's reported financial activity across periods.
